| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/02/2004 | CN1501937A Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 06/02/2004 | CN1501919A Quinoline derivatives and their use as antibiotics |
| 06/02/2004 | CN1501915A Bipiperidinyl-derivatives and their use as chemokine receptor inhibitors |
| 06/02/2004 | CN1501828A Dapd combination therapy with inosine monophosphate dehydrogenase inhibitor |
| 06/02/2004 | CN1501827A Ligands of the alpha-v-beta 6 integrin |
| 06/02/2004 | CN1501805A Endotoxin binding by lactic acid bacteria and bifidobacteria |
| 06/02/2004 | CN1501804A Acrochordon alleviation |
| 06/02/2004 | CN1500800A Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (HBV) |
| 06/02/2004 | CN1500781A Inhibitors of interleukin-1 beta converting enzyme |
| 06/02/2004 | CN1500520A Lichen bacteriophage and its production method thereof |
| 06/02/2004 | CN1500511A Cold proof medicine |
| 06/02/2004 | CN1500505A Medication composition for children 's virus pneumonia and its preparation method |
| 06/02/2004 | CN1500496A Preparation method of compound dispersed tablet of traditional Chinese medicine and use |
| 06/02/2004 | CN1500491A Release-controlled oral Roxithromycin formulation |
| 06/02/2004 | CN1500488A Oral colon-positioned medicine composition for curing bacillary dysentery |
| 06/02/2004 | CN1500482A Drug for diminishing inflammation and antibiosis |
| 06/02/2004 | CN1500475A Diffusional implantable delivery system |
| 06/02/2004 | CN1152051C Trichosanthin mutant and preparing method thereof |
| 06/02/2004 | CN1152022C Alpha-substituted. pyrimidine-thioalkyl and alkyl ether compounds |
| 06/02/2004 | CN1152021C Intermediate for preparing corticotropin release factors antagonistic agent and preparing method thereof |
| 06/02/2004 | CN1151845C Crystallographically stable amorphous sephalosporin compositions and process for producing the same |
| 06/02/2004 | CN1151841C Application of interferons(IFN) in preparation of pharmaceutics for stimulation of defence mechanism or immune reaction |
| 06/02/2004 | CN1151829C Medicine for treating lymphatic tuberculosis and lymphoma |
| 06/02/2004 | CN1151823C Medicine for preventing and treating cold and its preparing process |
| 06/02/2004 | CN1151811C Pain-relieving compound notoginseng mixture formulation |
| 06/02/2004 | CN1151799C Bacterial membrane fractions with adjuvant effect |
| 06/01/2004 | US6743924 Method for producing 1-substituted-1,2,3-triazole derivative |
| 06/01/2004 | US6743900 Viral protein antigen (especially influenza virus hemagglutinin), proteosome preparation and detergent; removing detergent by diafiltration or ultrafiltration |
| 06/01/2004 | US6743812 Pharmaceutical compositions and methods for use |
| 06/01/2004 | US6743811 Oxazalidinone compounds and methods of preparation and use thereof |
| 06/01/2004 | US6743810 Indol-3-yl derivatives |
| 06/01/2004 | US6743807 Cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α |
| 06/01/2004 | US6743802 Alkyne-aryl phosphodiesterase-4 inhibitors |
| 06/01/2004 | US6743795 Inhibitors for hepatitis b and acquired immune deficiency syndrome (aids) because they interfere with removal of rna strand from rna-dna hybrid formed during the reverse transcription of viral rna to dna |
| 06/01/2004 | US6743791 Heterocyclic inhibitors of ERK2 and uses thereof |
| 06/01/2004 | US6743788 Carbamate and oxamide compounds |
| 06/01/2004 | US6743778 Apo-AI/AII peptide derivatives |
| 06/01/2004 | US6743776 Cyclohexapeptides having antimicrobial activity |
| 06/01/2004 | US6743775 Slow release formulations comprising anionic polysaccharide |
| 06/01/2004 | US6743769 Active against bacteria and fungi that exhibit resistance to multiple current antibiotics; amino acid sequence selected from the group consisting of rp-1 (seq id no: 3), rp-8 (seq id no: 10), rp-11 (seq id no: 13) and rp-13 (seq id no: 14). |
| 06/01/2004 | US6743607 Production of complex carbohydrates |
| 06/01/2004 | US6743577 Methods of using cyanovirins to inhibit viral infection |
| 06/01/2004 | US6743431 Capsular polysaccharide adhesin antigen, preparation, purification and use |
| 06/01/2004 | US6743415 Delivery of anti-migraine compounds through an inhalation route |
| 06/01/2004 | CA2285058C Coincidence detection method, products and apparatus |
| 06/01/2004 | CA2270004C Stable mitoxantrone solutions |
| 05/27/2004 | WO2004044220A2 Flaviviris fusion inhibitors |
| 05/27/2004 | WO2004044191A1 Antimicrobial activity of antibodies producing reactive oxygen species |
| 05/27/2004 | WO2004043996A2 Ligands |
| 05/27/2004 | WO2004043984A1 SUBSTITUTED 9a-N-[N'-(BENZENESULFONYL)CARBAMOYL-Y-AMINOPROPYL]AND 9a-N-[N'-(B-CYANEOTHYL)-N'-(BENZENESULFONYL)CARBAMOYL-Y-AMINOPROPYL]DERIVATIVES OF 9-DEOXO-9-DIHYDRO-9A-AZA-9A-HOMOERITHROMYCIN A AND 5-0-DESOSAMINYL-9-DEOXO-9-DIHYDRO-9A-AZA-HOMOERITHRONOLIDE A |
| 05/27/2004 | WO2004043972A1 A new crystal form of adefovir dipivoxil and its composition |
| 05/27/2004 | WO2004043928A2 N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents |
| 05/27/2004 | WO2004043927A1 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials |
| 05/27/2004 | WO2004043911A2 N-cycloalkylglycines as hiv protease inhibitors |
| 05/27/2004 | WO2004043468A1 Screening method |
| 05/27/2004 | WO2004043467A1 Anti-viral compounds |
| 05/27/2004 | WO2004043453A1 Lysine mixture and apparatus and method for administering lysine |
| 05/27/2004 | WO2004043450A1 Sorbic acid as an anti-infective agent against coccidia |
| 05/27/2004 | WO2004043445A1 Topical parasiticide formulations and methods of treatment |
| 05/27/2004 | WO2004043435A2 Systemic delivery of antiviral agents |
| 05/27/2004 | WO2004043428A2 Buccal, polar and non-polar spray or capsule containing drugs for treating pain |
| 05/27/2004 | WO2004043355A2 Alpha, alpha-disubstituted benzylglycine derivatives as hiv protease inhibitors |
| 05/27/2004 | WO2004043339A2 Substituted cycloalkyl p1' hepatitis c virus inhibitors |
| 05/27/2004 | WO2004021968A3 Solution for ungual application |
| 05/27/2004 | WO2004016653A8 Bactericidal, anti-apoptotic, pro-inflammatory and anti-inflammatory peptides of heparin-binding protein (hbp) or human neutrophil elastase |
| 05/27/2004 | WO2004004702A3 Method to inhibit ischemia and reperfusion injury |
| 05/27/2004 | WO2003094902A3 Surface treatment of sars-infected lungs |
| 05/27/2004 | WO2003086412B1 Polyphosphonate derivatives for toothpaste compositions |
| 05/27/2004 | WO2003082926A9 Antimicrobial polymer conjugates |
| 05/27/2004 | WO2003075833A3 Screening method for orthopoxvirus antivirals |
| 05/27/2004 | WO2003073986A3 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 05/27/2004 | WO2003068820A9 Immunoglobulin igg3 as a marker for protecting against infectious viral diseases, and the uses of the same |
| 05/27/2004 | WO2003064448A3 Degp protease: cleavage site identification and proteolysis of a natural target in e. coli |
| 05/27/2004 | WO2003061589A3 Methods for treating diseases or conditions with peptide constructs |
| 05/27/2004 | WO2003059276B1 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
| 05/27/2004 | WO2003044183A8 Interleukin-2 gene transferred lymphokine activated killer cells |
| 05/27/2004 | WO2003039549A3 Selective antibacterial agents |
| 05/27/2004 | WO2003035050A3 Use of tyrosine kinase inhibitors for promoting hair growth |
| 05/27/2004 | WO2003025177A3 Sequences involved in phenomena of tumour suppression, tumour reversion, adoptosis and/or resistance to viruses and the use thereof as medicaments |
| 05/27/2004 | WO2002092827A3 Corona-virus-like particles comprising functionally deleted genomes |
| 05/27/2004 | WO2002062362A8 Antiviral and antibacterial composition |
| 05/27/2004 | US20040102630 For therapy of cancer, auto-immune diseases, cardiovascular diseases, infectious diseases, nephrological diseases, neurodegenerative diseases and viral infections |
| 05/27/2004 | US20040102605 For prevention/treatment of Pseudomonas infections |
| 05/27/2004 | US20040102508 Naphathalene derivatives which bind to the ep4 receptor |
| 05/27/2004 | US20040102506 Pyrazole compositions useful as inhibitors of ERK |
| 05/27/2004 | US20040102497 Novel inhibitors of IMPDH enzyme |
| 05/27/2004 | US20040102491 Antimicrobial agents |
| 05/27/2004 | US20040102484 Prodrugs of proton pump inhibitors |
| 05/27/2004 | US20040102482 Antibacterial Mutilins |
| 05/27/2004 | US20040102471 Viricides; anticancer agents |
| 05/27/2004 | US20040102460 Phosphodiesterase 4 inhibitors |
| 05/27/2004 | US20040102456 Aids therapy; viricides |
| 05/27/2004 | US20040102455 Autoimmune diseases; antiinflammatory agents; antiallergens; viricides; anticancer agents |
| 05/27/2004 | US20040102454 Anticancer agents; fungicides |
| 05/27/2004 | US20040102433 Bactericides; abtibiotic resistant grampositive bacteria |
| 05/27/2004 | US20040102432 Asthma, rhinitis therapy |
| 05/27/2004 | US20040102429 Zinc salt compositions for the prevention of dermal and mucosal irritation |
| 05/27/2004 | US20040102428 Chemokine receptor binding heterocyclic compounds |
| 05/27/2004 | US20040102418 Compounds for the treatment of inflammatory disorders |
| 05/27/2004 | US20040102414 Methods and compositions for treating flaviviruses and pestiviruses |